Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Hisse Senetlerindeki Sıralama #20442
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Hisse Fiyatı
$0.16328419
Piyasa Değeri
$204.14K
Değişim (1 gün)
4.35%
Değişim (1 yıl)
102.45%
Ülke
GB
Ticaret Fusion Antibodies plc (FAB)

Kategori

Fusion Antibodies plc (FAB) için P/S oranı
March 2026 itibarıyla P/S oranı TTM: 9.79
Fusion Antibodies plc şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/S oranı (TTM) 9.79'dir. 2024 yılının sonunda şirketin P/S oranı 1.88 idi.
Fusion Antibodies plc için P/S oranı geçmişi 2013 - 2026 arası
Her yılın sonunda P/S oranı
Yıl P/S Oranı Değiştir
2026 (TTM) 9.79 226.39%
2025 3.00 59.38%
2024 1.88 -45.47%
2023 3.45 6.43%
2022 3.24 -66.20%
2021 9.60 78.11%
2020 5.39 86.72%
2019 2.89 -54.34%
2018 6.32 -55.67%
2017 14.25 -22.61%
2016 18.42 -38.61%
2015 30.00 -20.48%
2014 37.73 -43.99%
2013 67.37 0.00%
Benzer şirketler veya rakipler için P/S oranı
Şirket P/S Oranı P/S Oranı Farkı Ülke
3.55 -63.73%
DK
9.90 1.13%
US
5.40 -44.83%
US
6.14 -37.31%
BE
12.90 31.71%
NL